← FDA DRUG APPROVALS

FDA ANDA · ANDA074598

HYDROMORPHONE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA074598
TYPE
ANDA
ORIGINAL APPROVAL
1997-06-19
LATEST ACTION
2007-08-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HYDROMORPHONE HYDROCHLORIDEDiscontinued
HYDROMORPHONE HYDROCHLORIDE 10MG/ML · INJECTABLE · INJECTION

Approval history

2007-08-29Labeling · Supplement 11AP
2003-05-14Labeling · Supplement 2AP
2002-12-03Manufacturing (CMC) · Supplement 7AP
2001-03-22Manufacturing (CMC) · Supplement 5AP
2001-03-22Manufacturing (CMC) · Supplement 6AP
2000-06-29Manufacturing (CMC) · Supplement 3AP
2000-06-29Manufacturing (CMC) · Supplement 1AP
2000-06-29Manufacturing (CMC) · Supplement 4AP
1997-06-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →